Biosimilar Infliximab- Feedback After A Nine Months Experience Of Their Use In The 37 Public Hospitals Of Paris
Nov 1, 2016, 00:00 AM
10.1016/j.jval.2016.09.568
https://www.valueinhealthjournal.com/article/S1098-3015(16)31934-9/fulltext
Section Title :
Health Care Use & Policy Studies
Section Order :
530
First Page :
A444
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)31934-9&doi=10.1016/j.jval.2016.09.568